Skip to main content
. 2019 Sep 17;20(18):4599. doi: 10.3390/ijms20184599

Figure 7.

Figure 7

PTX3 overexpression reduces the deposition of the complement C3 component. C3 immunohistochemistry and morphometric analysis in mock (A) and PTX3 (B) transfected MC17-51 injected s.c. in syngeneic C57BL/6 mice and in WT MC17-51 cells injected s.c. in wild type (C57BL/6) (D) and transgenic TgN(Tie2-hPTX3) (E) mice. Morphometric analysis shows a significant decrease of C3 tumor content following PTX3 overexpression by tumor cells (C) or by transgenic tumor stroma (F) when compared to their corresponding controls (A,D, respectively). * p < 0.05. Scale bar: (A,B,D,E) 60 µm.